What is the product of Laurus lab?
What is the product of Laurus lab?
Laurus Labs is a leading research and development (‘R&D’) driven pharmaceutical company in India with a leadership position in generic active pharmaceutical ingredients (‘APIs’) for select high-growth therapeutic areas of anti-retrovirals (‘ARVs’) Hepatitis C and Oncology.
Why Laurus Labs is increasing?
However, Laurus Labs in Q3 results conference call said the company is witnessing increased demand for the ARV business. “Increased demand for ARV business, witnessing commodity customers and formation sales from global multilateral agencies comes from January-March quarter (Q4) onwards.
Is Laurus Labs an MNC?
Laurus Labs is an Indian multinational pharma and biotech company headquartered in Hyderabad, India with its manufacturing plants located at Visakhapatnam, Hyderabad and Bengaluru. Its focus areas include active pharma ingredients, finished dosage forms, synthesis and biotechnology.
Is Laurus Labs a MNC company?
Is Laurus an MNC company?
Laurus Labs is an Indian multinational pharma and biotech company headquartered in Hyderabad, India with its manufacturing plants located at Visakhapatnam, Hyderabad and Bengaluru. Its focus areas include active pharma ingredients (APIs), finished dosage forms, synthesis and biotechnology.
Is Laurus Labs share split?
Laurus Labs had last split the face value of its shares from Rs 10 to Rs 2 in 2020. The share has been quoting on an ex-split basis from September 29, 2020.
When did Laurus lab split?
PREMARKET
| Splits History | ||
|---|---|---|
| Announcement Date | Old FV | Record Date |
| 30/04/2020 | 10 | 30/09/2020 |
Will Laurus Labs share increase?
Share Price is UP by 0.26% as on 09 Jun, 2022, 15:54 PM – NDTV Profit….Laurus Labs Ltd.
| Change | Change % |
|---|---|
| 1.50 | 0.27% |
| Updated:09 Jun, 2022, 16:01 PM IST |
Why Laurus Labs share price down?
Laurus Labs was down on profit booking after the company reported a robust set of July-September quarter (Q2FY21) numbers. The company’s profit after tax (PAT) was up 328 per cent year-on-year (YoY) at Rs 242 crore for the quarter on the back of strong operational performance.
What will be the future of Laurus Labs?
Laurus Labs Ltd. quote is equal to 553.850 INR at 2022-06-03. Based on our forecasts, a long-term increase is expected, the “Laurus Labs Ltd” stock price prognosis for 2027-05-28 is 916.829 INR. With a 5-year investment, the revenue is expected to be around +65.54%.
Why Laurus Labs is declining?
Laurus Labs fell 2.36% to Rs 463.45 after the company’s consolidated net profit declined 44% to Rs 154 crore in Q3 FY22 from Rs 273 crore in Q3 FY21. Revenues contracted by 20% YoY to Rs 1,029 crore during the quarter, due to lower demand of ARV APIs and formulations due to transient inventory correction.